 BetterLife Pharma Inc CSE:BETR OTCQB:BETRF FRA:NPAU said it has signed an agreement with the laboratory of Dr Adam L. Halberstadt at the University of California San Diego UCSD for TD-0148A preclinical behavioral pharmacology studies. 